Australia's Respiri gains most in six weeks on order from U.S. firm

Vitasora Health

04/02/2022 02:04

** Shares of medical devices and apps maker Respiri Ltd
 RSH.AX  jump as much as 10.2% to A$0.054, biggest intraday pct
gain since Dec. 23
    ** RSH secures a second order for additional wheezo devices,
digital wheezing monitoring devices, from U.S.-based telehealth
services provider mTelehealth  urn:newsml:reuters.com:*:nFWN2UE1MM
    ** Order represents revenues of about $24,000
    ** Co says targeted senior medical decision makers from over
600 of mTelehealth target customers will be provided with wheezo
devices for internal review, testing and pilot programs
    ** Stock hits highest level since Jan. 27
    ** More than 1 mln shares have changed hands, vs the 30-day
average of nearly 500,000 shares 
    ** As of last close, stock down ~23.4% this year

 (Reporting by Upasana Singh in Bengaluru)
 ((Upasana.Singh@thomsonreuters.com))